Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Club degli Investitori

Founders Bernardo Bertoldi Giancarlo Rocchietti

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 95
Average round size
info
The average size of a deal this fund participated in
$7M
Portfolio companies 64
Rounds per year 5.94
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 4
Key employees 9
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Health Care
  • E-Commerce
  • Software
  • Information Technology
  • Mobile
Summary

Club degli Investitori is the famous VC, which was founded in 2008. The main department of described VC is located in the Torino. The company was established in Europe in Italy.

This organization was formed by Giancarlo Rocchietti. The overall number of key employees were 9.

The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Club degli Investitori, startups are often financed by LVenture Group, 3LB Seed Capital Srl, Boost Heroes. The meaningful sponsors for the fund in investment in the same round are LVenture Group, Italian Angels for Growth, Boost Heroes. In the next rounds fund is usually obtained by iStarter, Rancilio Cube, Immobiliare.it.

The increased amount of exits for fund were in 2016. Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is constantly included in 2-6 deals per year. Opposing the other organizations, this Club degli Investitori works on 19 percentage points less the average amount of lead investments. The high activity for fund was in 2019. Considering the real fund results, this VC is 21 percentage points more often commits exit comparing to other organizations.

We can highlight the next thriving fund investment areas, such as Biotechnology, Genetics. Among the most popular portfolio startups of the fund, we may highlight Satispay, Talent Garden, FrescoFrigo - Healthy food close to you. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Italy.

Read more

Funds with similar focus

Funds from Italy
Funds with similar focus located in Italy:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
BBVA USA Alabama, Birmingham, United States
Durbell Bangkok, Krung Thep, Thailand
InfoCert Italy, Lazio, Rome
Intralinks New York, New York, United States
Mythic Ventures -
Pangaea Partners England, London, United Kingdom
Platinum Venture Capital Al Asimah, Al Kuwayt, Kuwait
Taishan XD (TXD) Ventures Beijing, Beijing, China
Zhongtian Zhixiang (Tianjin) Economic Consulting Center China, Guangdong, Tianjin

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Stema

Employment
Information Technology
16 Oct 2024 Milano, Lombardia, Italy

Lymphatica Medtech

Biotechnology
Health Care
Medical
Medical Device
08 Oct 2024 Vaud, Switzerland

Ephos

Hardware
Information Technology
Software Engineering
$8M23 Sep 2024 Milan, Lombardy, Italy

Glaut

$1M29 Apr 2024 Milan, Lombardy, Italy

Algor Lab

Artificial Intelligence
Computer
Primary Education
Software
$1M18 Dec 2023 Torino, Piemonte, Italy

CarpeCarbon

$2M15 Nov 2023 Turin, Piemonte, Italy

Largix

3D Printing
Printing
Robotics
10 May 2023 Israel, North District, Israel

TextYess

Advertising
E-Commerce
Marketing Automation
Mobile
$650K03 May 2023 Milano, Lombardia, Italy

Resalis Therapeutics

$11M22 Feb 2023 Torino, Piemonte, Italy

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Club degli Investitori?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 95
Average round size 7M
Rounds per year 5.94
Peak activity year 2021
Lead investments 2
Follow on index 0.33
Exits 4
Group Appearance index 0.63

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Stema

Employment
Information Technology
16 Oct 2024 Milano, Lombardia, Italy

Lymphatica Medtech

Biotechnology
Health Care
Medical
Medical Device
08 Oct 2024 Vaud, Switzerland

Ephos

Hardware
Information Technology
Software Engineering
$8M23 Sep 2024 Milan, Lombardy, Italy

Glaut

$1M29 Apr 2024 Milan, Lombardy, Italy

Algor Lab

Artificial Intelligence
Computer
Primary Education
Software
$1M18 Dec 2023 Torino, Piemonte, Italy

CarpeCarbon

$2M15 Nov 2023 Turin, Piemonte, Italy

Largix

3D Printing
Printing
Robotics
10 May 2023 Israel, North District, Israel

TextYess

Advertising
E-Commerce
Marketing Automation
Mobile
$650K03 May 2023 Milano, Lombardia, Italy

Resalis Therapeutics

$11M22 Feb 2023 Torino, Piemonte, Italy
Crunchbase icon

Content report

The following text will be sent to our editors: